Article | Open | Published:

Divergent responses to thermogenic stimuli in BAT and subcutaneous adipose tissue from interleukin 18 and interleukin 18 receptor 1-deficient mice

Scientific Reports volume 5, Article number: 17977 (2015) | Download Citation


Brown and beige adipocytes recruitment in brown (BAT) or white adipose tissue, mainly in the inguinal fat pad (iWAT), meet the need for temperature adaptation in cold-exposure conditions and protect against obesity in face of hypercaloric diets. Using interleukin18 (Il18) and Il18 receptor 1- knockout (Il18r1-KO) mice, this study aimed to investigate the role of IL18 signaling in BAT and iWAT activation and thermogenesis under both stimuli. Il18-KO, extremely dietary obesity-prone as previously described, failed to develop diet-induced thermogenesis as assessed by BAT and iWAT Ucp1 mRNA levels. Overweight when fed standard chow but not HFD, HFD-fed Il18r1-KO mice exhibited increased iWAT Ucp1 gene expression. Energy expenditure was reduced in pre-obese Il18r1-KO mice and restored upon HFD-challenge. Cold exposure lead to similar results; Il18r1-KO mice were protected against acute body temperature drop, displaying a more brown-like structure, alternative macrophage activation and thermogenic gene expression in iWAT than WT controls. Opposite effects were observed in Il18-KO mice. Thus, Il18 and Il18r1 genetic ablation disparate effects on energy homeostasis are likely mediated by divergent BAT responses to thermogenic stimuli as well as iWAT browning. These results suggest that a more complex receptor-signaling system mediates the IL18 adipose-tissue specific effects in energy expenditure.


Obesity-induced inflammation has important effects on morphological and functional properties of the adipocyte1. Interleukin (IL) 18 is a IL1 family of ligands and receptors, member, primarily associated with acute- and chronic-inflammation. Classically known as an interferon (IFN)-γ co-stimulator with IL12, a new modulatory role of IL18 in lipid and glucose metabolism has recently emerged2,3 Bacterial and inflammatory stimuli induces IL18 production by immune and non-immune cells in several metabolic organs/tissues, such as brain, liver, skeletal muscle, and specially adipose tissue (AT)4.

The IL18 receptor (IL18R) is composed of a ligand binding (IL18R1) and a signal-transducing chain or accessory protein (IL18RAP), both essential for MYD88 and IL1 receptor-associated kinase 1 (IRAK1) recruitment, subsequent translocation to the nucleus of nuclear factor (NF)-KB and pro-inflammatory gene transcription5,6. IL18 also triggers energy metabolism signaling pathways such as those of signal transducer and activator of transcription 3 (STAT3), as well as mitogen-activated protein, phosphoinositide-3 and AMP-activated protein kinases (MAPK, PI3K and AMPK)7,8. Central and peripheral IL18 activity seem to be tightly regulated by naturally occurring inhibitors: its high affinity soluble binding protein (IL18BP) and two splice variants of its receptor subunits, claimed to act as decoy receptors9,10,11. A second non-competitive ligand of IL18R1 with potent anti-inflammatory action, namely IL37, also exits12,13. However, the complex IL37/ IL18R1 does not bind IL18RAP. Instead, it recruits an inhibitory co-receptor, the IL1R family member SIGIRR (also known as IL1R8), to engage downstream signaling events14,15.

Within last decade, transgenic mice studies have been essential in determining the potential role of IL18 signaling in energy homeostasis2,8,16. Former studies of Netea2 and Zorrilla16 et al. showed that Il18 null mice develop mature onset obesity not only due to hyperphagia and hypoactivity, but also disturbances in peripheral nutrient metabolism17. Thus, Il18 deficiency decreased insulin sensitivity and increased fuel-efficiency, whereas central and/or peripheral IL18 administration reverses these effects. Additionally, Il18r1 absence and Il18bp overexpression in mice led to insulin resistance, hyperglycemia and obesity2. Conversely, skeletal muscle Il18-overexpression induces resistance to dietary obesity in mice through activation of AMPK signaling and lipid oxidation in this tissue8. Interestingly IL37 is also expressed in subcutaneous and visceral AT of human donors18. Though no IL37 mouse homolog has been cloned yet, mice with transgenic overexpression of human IL37 are resistant to high-fat diet (HFD), showed reduced AT macrophages, and upregulation of mitochondrial energy metabolism related genes in this tissue18.

AT is nowadays regarded as a diverse dynamic organ19,20. Brown AT (BAT) mitochondria inefficiently oxidizes fatty acids from BAT or white AT (WAT) lipolysis in response to cold or high-caloric diets, thereby dissipating energy as heat in an attempt to maintain body temperature and energy balance21,22,23. A main molecular mediator of this energy sparing mechanism is uncopling protein 1 (Ucp1)24,25. Data gleaned recently have shown that WAT depots develop brown fat features in response to thermogenic stimuli26,27. This browning process, more prominent in the inguinal subcutaneous fat (iWAT) than in other visceral fat depot, has attracted considerable interest due to its possible beneficial role on total energy metabolism28.

Over the last years it has became clear that skeletal muscle releases endocrine signals and metabolites such as irisin, IL6 or BAIBA with ability to induce a white to brown shift in adipocytes29,30. However, despite the relevant role of IL18/IL18R system in overall energy homeostasis, muscle and AT metabolism, and its reported interaction with different fat browning related signaling pathways, the specific involvement of this cytokine and its receptor on adipocyte plasticity remains unexplored. The present study aims to clarify the potential adaptive function of IL18 signaling on adipose tissue metabolism under different thermogenic stimuli: HFD and cold. For this purpose, we exposed Il18 and Il18r1 deficient mice to HFD and analyzed their metabolic phenotype. The impact of cold-exposure on BAT function and thermal responses was also analyzed, as were its effects on brown fat-like gene program in iWAT.


Differential responses of weight gain, food intake, BAT and iWAT Ucp1 gene expression to long-term HFD in Il18r1 and Il18-KO mice

Firstly, we explored changes in body weight, food intake, feed efficiency and body composition in Il18r1 and Il18-KO mice consuming a 60% HFD for 10 weeks. The metabolic performance of both strains was previously compared2,16 and found to be similar, thus only a group of Il18r1-KO mice fed a standard 4% fat diet as internal control was included. In this study, chow-reared Il18r1-KO mice exhibited significantly greater body weight than WT mice, with significant differences beginning already at 15 weeks of age (Fig. 1a). At the end of the experiment, Il18r1-KO mice were 8.6% heavier than WT controls and had significantly increased total fat but not lean body mass as determined by NMR analysis (Fig. 1b,c). Intra-abdominal dissected fat weight was 20% greater in Il18r1-KO compared to WT mice, whereas no effect was observed in iWAT mass (supplementary Fig. S1a). Relative fat content was, however, only slightly increased in Il18r1-KO mice at this age (supplementary Fig. S1b). Of note, detailed observation of body composition in mature (24 weeks old) mice revealed that though Il18r1-KO had similar body weight than Il18 deficient mice, they exhibited lower total and gonadal AT mass, smaller iWAT adipocytes cell size as well as lower BAT lipid accumulation (supplementary Fig. S2).

Figure 1: Divergent responses to dietary obesity in Il18r1 and Il18-KO mice.
Figure 1

(a) Body weight gain of WT, Il18r1 and Il18-KO mice fed a regular chow (CH) or a 60% high-fat diet (HFD) for 10 weeks (n = 8–13). (b,c) Fat and lean body mass as determined by NMR at the end of the study (n = 8–13). (d) Cumulative food intake per animal and cage (n = 4–6) and (e) feed efficiency across the 10-weeks feeding period (n = 8–13). (f) Hepatic triglyceride content and representative images (10X magnification) of liver sections from WT, Il18r1 and Il18-KO HFD mice stained with oil-red to determine the accumulation of neutral fat (left panel). (gi) Ucp1 mRNA levels in BAT and iWAT (n = 7). Data are expressed as mean ± SEM. *P < 0.05, **P < 0.01 and ***P < 0.001 versus respective WT mice fed the same diet by two-way ANOVA for repeated measurements ((a) CH: genotype F (1, 23) = 7.088, time F (10, 230) = 31.65 and genotype X time interaction F (10, 230) = 1.915; P < 0.05, P < 0.0001 and P < 0.05; HFD: genotype F (2, 31) = 12.85, time F (10, 310) = 173.8 and genotype X time interaction F (20, 310) = 2.463; P < 0.001 for all), and two-tailed Student´s t-test or one-way ANOVA.

Lack of Il18 but not Il18r1 in mice led to increased susceptibility to dietary obesity (Fig. 1a). Despite higher weight gain in Il18r1-KO mice during the initial four weeks on HFD, at the end of the study their body weight as well as total and abdominal adiposity were similar to those of WT mice (Fig. 1a,c, and supplementary Fig. S1a). On the contrary, final fat mass in Il18-KO was 80.4% greater than in WT mice (Fig. 1b), due to heightened abdominal and iWAT fat accumulation (1.6 to 2.2-fold increase vs WT controls; supplementary Fig. S1a). Absolute lean body mass was also slightly increased in animals deficient in the ligand or its receptor (Fig. 1c). Concordant with overweight and adiposity, leptin levels were greater in Il18 but not in Il18r1-KO compared with WT animals (Table 1). Additionally, reflecting a disturbed glucose metabolism, HFD-fed Il18-KO mice showed increased non-fasted glucose levels, and yet unexpectedly higher adiponectin levels than WT mice (Table 1).

Table 1: Serum parameters in Il18r1 and Il18-KO mice after ten weeks of HFD.

Il18 deficiency in mice has been associated with increased food consumption and fuel efficiency on both low- and high-fat diets as well as reduced energy expenditure2,16. In the present work, Il18r1-KO and WT mice ate similar amounts of calories from each diet (Fig. 1d), but only exhibited greater feed efficiency when maintained on regular chow (Fig. 1e). Consistent with previous published results16, Il18-KO HFD mice were hyperphagic and gained 1.7-fold more body weight than WT mice per unit energy consumed (Fig. 1e).

Feed efficiency differences depending on the dietary fat amount suggested that Il18r1-KO were less obesity-prone than Il18-null mice, through either divergence in substrate utilization and/or energy expenditure. In support of the first hypothesis, subtle differences in whole-fat oxidation indices have been reported between these two transgenic mice models8,16,17. Hence, while mature Il18-KO mice consuming HFD ad libitum have increased respiratory exchange ratio (RER), this effect is only evident in mature Il18r1-KO mice after fasting and refeeding. In the present study and reflecting a failure in liver lipid metabolism, hematoxylin-eosin staining revealed increased hepatic steatosis (Fig. 1f), paralleled by higher triglyceride content (Fig. 1g) as well as markedly decreased serum triglyceride levels in HFD-fed mice with absence of the ligand but not of the receptor (Table 1). Additionally, we examined BAT metabolism, known to contribute to plasma triglyceride clearance by oxidizing free fatty acids for heat production26,31, and the alternative pathway dissipating energy through increased thermogenic activity by iWAT browning. Ucp1 gene expression in BAT and iWAT samples from the diet intervention study were assessed (Fig. 1g–i). HFD-fed Il18-KO displayed increased BAT weights (Supplementary Table S1) as well as lower BAT and iWAT Ucp1 mRNA absolute or relative levels (per μg of mRNA) than WT mice raised on the same diet, suggesting reduced thermogenic capacity as part of the obesogenic mechanism. Of note, the HFD-induced down-regulation of iWAT Ucp1 mRNA levels was blunted in Il18r1-KO mice, which exhibited higher Ucp1 mRNA content in this fat depot than that of WT controls. No differences were found in BAT weight and either total or relative Ucp1 gene expression between WT and Il18r1-KO mice irrespective of diet.

Lack of Il18r1 in young mice results in decreased energy expenditure on standard chow but not on HFD

Next, we analyzed the effect of diet composition on the different components of daily energy expenditure (EE) in young pre-obese Il18r1-KO mice. For this purpose, mice were initially fed standard chow for two days and subsequently HFD-challenged for another 48 hours. Indirect calorimetry revealed that, under standard diet, EE in Il18r1-KO mice was significantly lower in relation to WT mice (Fig. 2a). The decrease was mainly observed during night time (Fig. 2d), with a slight but not significant reduction in average EE values during day time (WT CH-13.985 ± 0.125 vs. Il18r1-KO CH-12.236 ± 0.88 Kcal/kg/h; P = 0.077). This nocturnal reduction in EE was related to a diminished physical activity in these animals (Fig. 2b), as demonstrated by 29% lower dark-phase total locomotor activity in Il18r1-KO compared to WT mice (Fig. 2e). Once switched to HFD, Il18r1-KO mice raised their EE values to WT mice levels (Fig. 2a,d), without changes in nocturnal activity (Fig. 2b,e). There were no significant RER differences between genotypes whether fed chow or HFD (Fig. 2c,f). These data suggest that Il18r1-KO mice might display an increased diet-induced thermogenesis that obscures the reductive effect of activity on total EE.

Figure 2: High fat diet challenge increased EE in Il18r1-KO mice.
Figure 2

(ac) Energy expenditure (EE), total locomotor activity and respiratory exchange ratio (RER) were measured at room temperature in 8-weeks old WT and Il18r1-KO mice fed regular chow (CH, left panel) and then switched to high fat diet (HFD, right panel) for consecutive periods of 48 h. Black horizontal bars depict the dark period in a 12:12 light-dark cycle. (df) Average EE, locomotor activity and RER values over the light and dark period before (left panel) and after HFD challenge (right panel). Data are expressed as mean ± SEM. (n = 6). *P < 0.05 and **P < 0.01 versus respective WT mice fed the same diet by two-way ANOVA for repeated measurements ((a) CH: genotype F (1, 10) = 5.087, time F (48, 480) = 13.70 and genotype X time interaction F (48, 480) = 1.706; P < 0.05, P < 0.0001and P < 0.01; (b) CH: genotype F (1, 10) = 5.753, time F (48, 480) = 12.32 and genotype X time interaction F (48, 480) = 1.655; P < 0.05, P < 0.0001 and P < 0.01) and two-tailed Student´s t-test.

Divergent responses to acute cold-exposure in Il18r1 and Il18-KO mice

To further dissect whether lack of Il18 or its receptor results in altered whole-body thermogenic capacity, we measured body temperature before and during 24 h cold-exposure (Fig. 3a). Basal rectal temperatures were similar in WT, Il18r1 and Il18-KO mice (WT = 36.9 °C ± 0.1, Il18r1-KO = 37.2 °C ± 0.2 and Il18-KO = 36.9 °C ± 0.1). In contrast, after transfer to a cold-environment, significant genotype and time effects as well as genotype-time interactions on rectal temperature values were observed. Thus, over the first 4 hours at 4 °C, whereas Il18-KO were less cold-tolerant than WT mice, Il18r1-null mice exhibited better ability to maintain their body temperature (Fig. 3a), and increased total BAT Ucp1 mRNA expression despite similar tissue weight in all three genotypes (Fig. 3b and supplementary Table. S1). BAT Il18 mRNA analysis revealed that Il18r1 deficiency in mice is associated with decreased gene expression levels of its ligand cytokine, which were restored to WT mice values after 4 hours at 4 °C (Fig. 3c). By 24 hours, rectal temperature returned to ≈2 °C below its basal values in all mice groups and the genotype effect disappeared. Similar responses were observed when either heterozygous Il18r1-KO and WT littermate mice or Il18r1-KO and WT mice generated from mating F1 offspring from Il18r1 heterozygote breeders were challenged to acute cold (supplementary Fig. S3a-b).

Figure 3: Divergent responses to short time cold exposure of rectal and BAT temperature, and BAT Ucp1 mRNA content in Il18r1 and Il18-KO mice.
Figure 3

(a) Body temperature at different times after cold exposure (4 °C) in WT, Il18r1 and Il18-KO mice (n = 8–12). (b,c) BAT Ucp1 and Il18 mRNA levels after 4 h of transfer to a cold room (n = 5–6). (d) Representative infrared thermal images with quantification of interscapular (TiScap) and lumbar back (TBack) skin temperature at 22 °C and after 1 h at 4 °C (n = 5–8). (e,f) Average changes in TiScap and TBack, respectively and (g) difference TiScap-TBack that reveals the heat that is locally generated under the interscapular skin (i.e., potentially of iBAT origin) (n = 5–8). Data are expressed as mean ± SEM, *P < 0.05 and ***P < 0.001 versus WT control at the same temperature and #P < 0.05 and ###P < 0.001 versus animals from the same genotype at room temperature by two-tailed Student’s t-test and one way ANOVA or two-way ANOVA for repeated measurements ((a) genotype F (2, 25) = 5.101, time F (4, 100) = 219.5 and genotype X time interaction F (25, 100) = 3.061; P < 0.05 and P < 0.0001; (d–f) TiScap: genotype F (2, 16) = 7.441 and genotype X temperature F (2, 16) = 6.314, P < 0.01 for both; TBack: genotype F (2, 16) = 0.1543 and genotype X temperature F (2, 16) = 0.4903, P > 0.05 for both; TiScap-TiBack: genotype F (2, 16) = 10.36, temperature F (1, 16) = 75.90 and genotype X temperature F (2, 16) = 7.113; P  <  0.01, P < 0.001 and P < 0.01, respectively).

The effect of short-term cold-exposure on BAT activation was also assessed by non-invasively infrared-thermography32 in Il18r1 and Il18-KO mice. For this purpose, animals kept at 22 °C were transferred to a cold-room for one hour, and temperatures of areas surrounding interscapular BAT (TiScap) and lumbar back skin (TBack) were measured (Fig. 3e–g). We found significant genotype effect and genotype and temperature interactions on TiScap but not TBack. Subsequent post-hoc tests revealed significantly lower cold-challenge induced reductions of TiScap in Il18r1-KO than in WT mice (Fig. 3e,f).

As expected33, reflecting BAT activation and thermogenesis, the interscapular skin laying directly above BAT cooled down less than the lumbar back skin. Temperature differences between both regions were clearly seen on TiScap-TBack (Fig. 3g), which was markedly increased in Il18r1-KO in relation to WT mice.

Lack of Il18r1 and Il18 in mice differentially modulates thermogenic program in iWAT and BAT after long-term cold-exposure

To gain further insight on the effect of IL18 system on BAT and iWAT thermogenic capacity and nonshivering-thermogenesis acquisition24, we first examined Ucp1 protein levels per depot after 5-days of cold-exposure in Il18r1 and Il18-KO mice. Whereas BAT weight and total Ucp1 protein content were unaffected by lack of the ligand or the receptor, iWAT protein synthesis per μg of tissue was found to be enhanced in Il18r1 and reduced in Il18-KO mice in comparison to WT controls (supplementary Table. S1 and Fig. 4a,b). Consistently, abundant patches of multilocular brown-like adipocytes found in iWAT from Il18r1-KO mice, were totally absent in Il18-null animals tissue sections (Fig. 4c). No effect of lack of Il18 and Il18r1 were found in total BAT Ucp1 mRNA content (Fig. 4d). Conversely, as early as the second day of cold-challenge and onwards, significantly reduced uncoupling gene expression was observed in iWAT from Il18-KO but not in Il18r1-KO mice (Fig. 4e). To determine possible mediators of the IL18 system effects on cold-induced browning process in iWAT, we evaluated the expression of two major BAT markers: PR domain containing 16 (Prdm16) and peroxisome proliferative activated receptor, gamma, coactivator 1 alpha (Ppargc1a). Il18r1 deficiency upregulated both Prdm16 and Ppargc1a mRNA levels in 5-days cold-exposed mice (Fig. 4f,g), whereas its gene expression was lower in Il18-KO mice in comparison to WT mice after two days at 4 °C (Fig. 4f).

Figure 4: Divergent responses to long-term cold exposure of Ucp1 protein content, and BAT markers gene expression in BAT and iWAT from Il18r1 and Il18-KO mice.
Figure 4

(a,b) Ucp1 protein levels in BAT and iWAT, and (c) representative pictures (20X magnification) of iWAT histology from WT, Il18r1 and Il18-KO mice maintained at room temperature or after 5 days of cold exposure. Black arrows depict multilocular adipocytes presence. (d) Ucp1 mRNA content in BAT and (e–g) Ucp1, Prdm16 and Ppargc1a mRNA levels in iWAT of WT, Il18r1 and Il18-KO mice acclimated to either 22 °C or 4 °C for 2 and 5 days (n = 5). For absolute Ucp1 and Ucp1 protein and mRNA levels in BAT mean value of WT mice at 4 °C (a) or 22 °C (d) were set to 1.0 and the other values expressed relative to this. Data are expressed as mean ± SEM. *P < 0.05, and ***P < 0.001 versus WT controls at the same temperature by one way ANOVA.

Cold exposure rapidly promotes alternative activation of adipose tissue macrophages (ATMs), which secrete catecholamines and anti-inflammatory cytokines to induce lipolysis as well as BAT and iWAT thermogenic gene expression34,35. To further clarify whether the effect of Il18r1 deficiency in iWAT activation was mediated by alternative macrophage polarization, we measured the gene expression of the alternative or classic activation markers arginase (Arg1) and inducible nitric oxide synthase (Nos2)34 in iWAT and BAT samples of 4-hours cold exposed Il18r1 and Il18-KO and WT mice (Fig. 5a,b). Higher Arg1 mRNA levels were found in iWAT but not in BAT from Il18r1 in relation to WT mice, but not in Il18-KO mice. No differences were observed in Nos2 mRNA content in both tissues between genotypes. Similar results were obtained in Il18r1-KO and WT mice generated from mating homozygous F1 offspring from Il18r1 heterozygote breeders (supplementary Fig. S3c). This specific effect of Il18r1 deficiency in macrophages activation seemed not to be mediated by changes in locally produced Il18, as iWAT Il18 mRNA levels were equally down-regulated by acute cold exposure in WT and Il18r1-KO mice (Fig. 5c).

Figure 5: Cold exposure acutely promotes higher alternative polarization of infiltrated macrophages in iWAT from Il18r1-KO mice.
Figure 5

(a,b) Alternative and classic macrophage polarization (Arg1 and Nos2) in iWAT and BAT, and (c) Il18 mRNA levels in iWAT from WT, Il18r1 and Il18-KO mice after 4 h of transfer to a cold room (n = 5–6). Data are expressed as mean ± SEM, *P < 0.05 versus WT control at the same temperature by one-way ANOVA.

Chronic central IL18 administration induces BAT-like morphology in iWAT from Il18r1-KO mice

To further explore whether centrally produced Il18 might play a role in the observed changes in adipose tissue plasticity in cold- exposed Il18r1-KO mice, we also analyzed the hypothalamic mRNA content of this cytokine and its binding inhibitor, Il18bp. Similarly reduced gene expression levels for Il18 and Il18bp were found in the hypothalamus of Il18r1 deficient mice as compared to WT controls, and this difference disappeared shortly upon cold challenge (Fig. 6a,b), whithout changes in Il18/Il18bp mRNA ratio (data not shown). Therefore, we determined whether central IL18 replacement in Il18r1-KO mice could resemble the effect of cold exposure in the promotion of iWAT browning. For this purpose, recombinant IL18 was chronically i.c.v. administered (20 μg/7days) to WT and Il18r1-KO mice. A higher IL18 dose has been previously shown to acutely reduce food intake in WT but not in Il18r1-KO mice17. In agreement with these data chronic IL18 icv infusion decreased food intake and body weight (Fig. 6c,d), along with significant reductions in total, abdominal, subcutaneous WAT and BAT content, in WT but not in Il18r1 deficient animals (Fig. 6e–h). Subsequent histological analysis revealed, however, that central IL18 infusion induced the emergence of multi-locular brown-like adipocytes in iWAT tissue samples from Il18r1-KO mice (Fig. 6i).

Figure 6: Chronic central IL18 administration induces BAT-like morphology in iWAT from Il18r1-KO mice.
Figure 6

(a) Hypothalamic Il18 and (b) Il18bp mRNA levels in WT and Il18r1-KO mice maintained at room temperature and after 4 h of transfer to a cold room (n = 6–13). (c) Cumulative food intake, (d) body weight and percentage of (e) total, (f) abdominal and (g) subcutaneous fat mass, and (h) BAT weight in relation to body weight of WT and Il18r1-KO mice i.c.v. treated with either saline or recombinant IL18 (20 μg/7days) (n = 4–6). (i) Hematoxylin-eosin staining of iWAT tissue (20X magnification). Data are expressed as mean ± SEM. *P < 0.05, versus respective WT control mice by two-tailed Student’s t-test.


We report herein that the IL18/IL18R1 system plays an important role on energy homeostasis. The primary finding is that deletion of the ligand or the receptor leads to divergent responses in BAT and iWAT in terms of beige reprogramming. Our data provides mechanistic insight regarding differential effects exerted by genetic ablation of either the ligand or its receptor.

In agreement with previous data16,17, in our study absence of Il18 caused extreme susceptibility to dietary obesity due to increased food intake and feed efficiency, with the latter being an indirect sign of altered macronutrient utilization or decreased EE. In line with the second option, 10 weeks-consumption of HFD in Il18-KO mice resulted in significantly increased BAT weight, lowered BAT and iWAT Ucp1 gene expression. A novel unexpected finding of the present work is that the lower obesogenic effect of HFD on Il18r1-null mice is associated with upregulated iWAT but not BAT Ucp1 mRNA content. In addition, the subtle differences observed in overall fat mass content as well as in BAT and iWAT gross anatomy between mature obese Il18r1 and Il18-KO mice raised on a LFD, also point to the existence of divergences between these knockout mice strains in the thermogenic activity of both tissues.

Our data indicate that lack of Il18r1 in mice is associated with decreased whole-body EE and ambulatory activity as early as 8 weeks of age and this effect is blunted by HFD challenge. Such observations provide logical and complementary mechanisms8 for obesity development in this knockout strain. Increased energy expenditure (diet induced thermogenesis) and activity levels in the face of a HFD have been previously reported by other authors36,37. In agreement with these observations, dietary change caused an increment of EE and locomotor activity in both WT and Il18r1-KO mice. However, only in the case of EE this effect occurred with a higher intensity in animals lacking the alpha chain of the Il18 receptor (3.6 kcal/day vs 1.7 kcal/day), and blunted the previous differences between genotypes. Of note, Zorrilla and coworkers have recently demonstrated that the dietary obesity prone Il18-KO mice exhibited stable reduced whole body energy expenditure when transferred from a low to high fat diet17. Collectively these results are also in agreement with a divergence in diet induced thermogenesis between Il18 and Il18r1-KO mice, which might justify their different susceptibility to dietary obesity.

To ascertain the specific role of BAT thermogenic capacity in the metabolic phenotype of Il18r1 and Il18-KO mice, an acute 24 hours cold-exposure experiment was performed. We again found striking differences in rectal temperatures of Il18r1 and Il18-KO mice at 2 and 4 hours-time points of cold-exposure, which were higher and lower than those of WT mice housed at the same temperature. Although thermographic recordings of iBAT temperature and the higher absolute BAT Ucp1 gene expression in cold-exposed Il18r1-KO are in line with increased thermogenic activity of this tissue32, we failed to detect significant changes in those parameters in Il18-KO mice. Moreover, BAT activation in Il18r1-KO mice seems to be only a transient state, since a more prolonged cold-challenge (5 days) also failed to induce similar increases in either total Ucp1 mRNA or protein levels.

Long term cold-challenge is also known to induce specific genetic and morphological changes in iWAT leading to a more BAT-like appearance38,39. Factors central to iWAT adaptation to cold include Prdm16, a master co-regulator critical for the commitment toward brown adipocyte lineage40, and its downstream target Ppargc1a, a transcriptional co-activator of nuclear receptors that is necessary for maximal induction of mitochondrial biogenesis and Ucp1 expression41. Prdm16 adipocyte-specific deletion in mice caused minimal effects on classical BAT, but markedly inhibited beige adipocyte function in iWAT following cold-exposure or β3-agonist treatment42. Besides dietary induced obesity, these mice developed insulin resistance specifically affecting WAT and liver as well as hepatic steatosis. Remarkably, in the present study Prdm16 but also Ppargc1a gene expression was significantly decreased in the iWAT from 2-days cold-exposed Il18- KO mice. Lack of Il18 also caused virtual absence of iWAT multilocular adipocytes, which was related to markedly decreased Ucp1 protein content specifically in this tissue. Of note, adipo-Prdm16-null mice did not show core-temperature alterations following 6 hours at 4 °C42, which is also in consistence with our data. Altogether the present findings demonstrate that ablation of Il18 blocks the emergence of inducible brown adipocytes and its associated thermogenesis, and this effect could contribute to the metabolic disturbances in HFD-fed Il18-KO mice, previously described2,16,17 and confirmed herein (i.e extreme susceptibility to dietary obesity, increased basal glucose levels and hepatic steatosis). By contrast, Il18 binding receptor ablation markedly induced beige reprogramming in long-term cold-exposed mice and increased Ucp1 gene expression, as we observed in iWAT from HFD-fed mice in correlation with lower fat mass content, glucose levels and hepatic triglyceride content.

Collectively these phenotypic divergences between Il18 and Il18r1 null mice suggest the existence of either i) compensatory adaptions to the lack of Il18r1 that overcome the effects of Il18 deletion or ii) a more complex receptor/signaling system for IL18.

Since experimental evidence does not support a role of IL37 as IL18R1 antagonist18,43, additional compensatory adaptations in response to knockout of Il18r1 in mice might be related to inhibition of the IL37 signaling through this receptor. IL37 is only stably produced in inflammatory conditions as a negative feedback inhibitor to limit excessive inflammation damage14. Previous research has identified a seemingly paradoxical increase in inflammatory signaling in cells lacking the Il18r1 chain, thus the lack of IL37 action may underlie this phenotype. Our results indicates, however, that iWAT browning but not BAT activation in Il18r1 null mice coincides with increased mRNA expression of Arg1, a classsical marker of anti-inflammatory alternative macrophage polarization34. Recent studies have highlighted the importance of specific macrophage subsets presence in regulating BAT and iWAT function34,35,44. Obesity results in increased infiltration of WAT tissues by classically (M1) activated macrophages, which amplify inflammation and insulin resistance by secreting high amounts of pro-inflammatory cytokines (IL6, IL10 and Nos2)45,46. Conversely, alternative or anti-inflammatory macrophages (M2), which promote insulin sensitivity in visceral WAT by releasing IL10 and TGF-beta, are primarily recruited to BAT and iWAT in response to cold and produce cathecolamines to sustain adaptative thermogenesis47. Alternative activation of infiltrated macrophages is mainly governed by IL4 and IL13 signaling and maintained by IL10 but also IL6 through induction of IL4 receptor in these cells48. Interestingly, cold exposure-induced increases in iWAT UCP1 protein content are blunted in Il6-KO mice29 and this cytokine is a fundamental determinant in fat browning activation during human cancer cachexia49.

As other IL1 family members, IL37 also down-regulates inflammatory responses through intracrine signalling mechanisms independent of its cell membrane receptors15,43. Whether disparate results regarding thermogenic gene program activation in Il18 and Il18r1-KO mice iWAT are related to yet unknown IL37 mouse homolog intracellular actions is another possibility worth investigating.

It is well established that IL18 mediates its biological effects in a variety of organ systems and cell types9 through stepwise binding to IL18R1 and IL18RAP, and subsequent juxtaposition of the intracellular toll/interleukin-1 receptor (TIR) domains of both receptors50. However, additional truncated variants of IL18R1 and IL18RAP, lacking this domain essential for recruitment of MYD88 adaptor protein and subsequent activation of (NF)-ΚΒ and MAPK pathways, have been reported in humans and rodents (arbitrary named type II receptors)10,11,51. Though their exact role is yet to be fully established, they are proposed to act as competitors of the canonical receptors in heterodimer formation thereby inhibiting IL18 actions10,11.

While direct peripheral effects of IL18 (i.e muscle specific) on lipid oxidation have been recently demonstrated8, several previous and present findings also suggest a central mode of action for this cytokine in controlling energy homeostasis and metabolic function. IL18R heterodimer subunits and spliced variants are found to be widely distributed across the brain4,10,11. Besides the hypothalamus and the amygdala, the highest level of expression are detected in the hypothalamic ventromedial and paraventricular nucleus, key centers in the control of food intake, BAT thermogenesis and iWAT browning52,53. According with this pattern of expression here we show that chronic IL18 administration (7-days) suppresses cumulative low-fat chow (LFD) intake in an Il18r1 dependent manner. These results are in agreement with a previous report that i.c.v IL18 in higher dose/dose time (1 or 2 nmol ≤40 μg, acutely administered) inhibits 24-h HFD intake in fasted WT but not in Il18r1 deficient mice. However, our present observation that i.c.v. IL18 infusion induces a slight emergence of brown-like features in Il18r1-KO iWAT samples, raises the question whether the short forms of the receptor play an additional role in energy homeostasis activating browning in response HFD or cold challenge. In line with this hypothesis, we also report that lack of Il18r1 induces compensatory down-regulations of hypothalamic Il18 and Il18 bp as well as BAT Il18 gene expression, and acute cold challenge blunts these effects. Given the reported low levels of CNS expression of Il18r short variants9,10,11, additional transgenic mice with conditional and tissue specific deletion of these receptor isoforms would be helpful to decipher the exact site and mechanisms of action.

In summary our data show that lack of Il18 but not Il18r1 in mice led to an increased susceptibility to dietary obesity. Detailed analysis of the different compartments involved in energy homeostasis indicate that the disparate effects exerted by genetic ablation of the ligand and the receptor are likely mediated by divergent responses to thermogenic stimuli in BAT as well as the capacity of subcutaneous AT browning. Understanding of the molecular mechanisms by which ablation of IL18R1 exerts its effects may provide a novel therapeutic approach to treat obesity.

Material and Methods

Ethics statement

Animal experimental procedures were conducted according to the regulations of the European Communities directive of September 2010 (2010/63/ECC) and Spanish legislation (BOE 34/11370–421, 2013) regulating animal research. All the research procedures included in this study were approved by University of Santiago de Compostela Bio-ethics Committee.


8-weeks old Il18 and Il18r1 deficient mice (B6.129P2–Il18 < tm1Aki >/J and B6.129P2–Il18r1 < tm1Aki >/J) and their congenic controls C57BL/6J mice (WT), were used in all experiments. For the diet intervention and cold exposure studies animals were initially bred on site from homozygous pairs purchased from The Jackson Laboratory (Charles River Laboratories, Barcelona, Spain; stock numbers 004130, 004131 and 000664, respectively), and housed under 22°C temperature and 12 hours light-dark conditions. Subsequently, for cold-challenge confirmatory experiments, central IL18 infusion, and hypothalamic Il18 and Il18bp mRNA assays we used heterozygous Il18r1-KO and WT littermate mice as well as in Il18r1 deficient and WT animals generated from homozygous breeding pairs, which were F1 offspring from Il18r1-KO heterozygote breeders54.

Diet intervention

Mice were fed either standard rodent chow (CH: 13% fat, 67% carbohydrate and 20% protein on a caloric basis; 2014S Harlan Teklad, Barcelona, Spain) or high fat diet (HFD: 60% fat, 20% carbohydrates and 20% protein on a caloric basis; D12492, Research Diets, New Brunswick, NJ, USA) for 10 weeks. Body weight and food intake were measured weekly in 4–6 cages per treatment group (2–3 animals/cage). At the end of the study period whole-fat and lean mass content was measured by NMR spectroscopy (EchoMRI–700™, Echo Medical Systems, Houston, TX, USA). Animals were sacrificed by decapitation under ketamine-xylazine anesthesia for blood collection and, fat depots dissection and weighing55.

For complementary body weight and body composition analysis a third group of WT, Il18 and Il18r1-KO mice (5–6 mice/genotype) fed standard rodent chow (2019s, Teklad Global, Harlan, Spain) were used. At 24 weeks of age and prior sacrifice, body length was measured with a ruler from nose to anus on sedated animals. iWAT and BAT samples were removed quickly and fixed in 4% paraformaldehyde for subsequent histological analysis.

HFD challenge, energy expenditure and locomotor activity measurements

Analysis of energy metabolism by indirect calorimetry was performed in independent groups of WT and Il18r1-KO mice (6 mice/genotype). After 2 days of acclimation, mice were individually monitored in a TSE LabMaster system (TSE Systems, Bad Homburg, Germany) as previously described55. Data on gas exchanges, locomotor activity, and food intake were collected every 20 min for two consecutive 48 h-periods of feeding chow and HFD. Activity monitoring was performed simultaneously with infrared sensor pairs arranged in strips for horizontal (X level) and vertical (Z level) activity. Respiratory exchange ratio (volume of CO2 produced per volume of O2 consumed (ml/kg of body weight/ per h), and energy expenditure were also calculated for the light and dark phases.


For short- and long term-cold-challenge experiments individually housed mice with free-access to standard chow diet were exposed to a 4 °C ambient temperature for 1, 4 or 24 hours, and 2 or 5 days. Rectal or surface temperatures were collected at indicated times using a digital thermometer (RS, Barcelona, Spain) or an infrared thermographic camera (Therma E40; FLIR, Croissy-Beaubourg, France). Animals (8–12 mice/genotype) were acclimated to individual cages and rectal probing during three days. As infrared radiations are blocked by Plexiglas or stainless steel, one day before the thermographic recordings start, mice (5–8 mice/genotype) were lightly anesthetized with ketamine–xylacine and shaved between the scapulae and over the lumbar back region, to expose the skin for temperature readings in these areas (TiScap and TBack, respectively)33. Each infrared digital image simultaneously captured TiScap and TBack, and was analyzed with a specific software package (FLIR Tools Software). The temperature surrounding interscapular and lumbar back region for one particular animal was calculated as the average temperature in defined areas recorded by analyzing those pictures32. After completion of the studies, mice were sacrificed and, iWAT and BAT samples for histological or expression studies were dissected out, frozen on dry-ice and stored at –80°C.

Intracerebroventricular infusions

To assess the long-term central effects of the IL18 system on food intake, body composition and iWAT morphology, 10–11 weeks old Il18r1-KO and WT mice (4–7 mice/genotype/treatment) were infused ICV with saline or recombinant IL18 (20 μg/mouse/7 days, Sino Biological, Inc., Beijing, China)56. For this purpose, brain infusion canulae were placed stereotaxically into the lateral ventricle as previously described56. A catheter tube was connected from the brain infusion cannula to the osmotic minipump (model 1007D, total volume 100 μL, flow rate 0.5 μL/h; Alzet Osmotic Pumps, Durect, CA, USA) flow moderator.

Hematoxylin/eosin staining

iWAT and BAT samples were fixed 24 hour in 10% formalin buffer and then were dehydrated and embedded in paraffin by a standard procedure. Sections of 3 μm were made in a microtome and staining in a standard Hematoxylin/Eosin Alcoholic (BioOptica, Milan, Italy) procedure as manufacture instructions.

Oil Red Staining

Frozen 8 μm-sections of the livers were cut on a cryostat and stained in filtered Oil Red O for 10 minutes. Sections were washed in distilled water and counterstained with Mayers hematoxylin for 3 minutes. Sections were mounted in aqueous mountant (glycerin jelly).

Levels of Serum Metabolites and Hormones

Serum glucose and triglyceride levels were assessed using commercial kits based on a enzymatic colorimetric method (Glucose-TR and Triglycerides-LQ, Spinreact, Girona, Spain). Serum leptin and adiponectin levels were measured using enzyme-linked immunosorbent assay kits (Merck Millipore, Madrid, Spain) following the manufacturer’s instructions.

Liver Triglyceride content

Liver samples (40–50 mg) were extracted in 1 ml isopropanol. After centrifugation at 4 °C at 10000 rpm for 15 min, 10-μl aliquots of supernatant were added to 200 μl reagent (Triglycerides-LQ, Spinreact, Girona Spain) for enzymatic colorimetric determination of triglyceride concentration.

Real time qPCR

Total RNA was extracted from frozen iWAT and BAT samples using TRIzol according to the manufacturer’s instructions (Invitrogen, Barcelona, Spain). Reverse transcription and qPCR (TaqMan®, Applied Biosystems, Barcelona, Spain) were performed in duplicates as described earlier55. Complementary DNAs were synthesized from 500 ng of total RNA in a 30 μl reaction using 200 U Maloney murine leukemia virus reverse transcriptase and random hexamer primers (Invitrogen, Barcelona, Spain). Quantitative real-time PCR was performed using an ABI PRISM 7300 HT Sequence Detection System (Applied Biosystems; Foster City, CA, USA) with 2 μl aliquots of the resulting cDNAs and specific Taqman qRT-PCR primers and probes (Supplementary Table 2). Amplification of 18S rRNA (Rn18S) was performed at the same time to normalize the level of mRNA expression. A non template reaction was included during each experiment to control for DNA contamination. The PCR cycling conditions included an initial denaturation at 50 °C for 10 min followed by 40 cycles at 95 °C for 15 s and 60 °C for 1 min. A standard curve was run in each assay, with an arbitrary value assigned to the highest standard and corresponding values to the subsequent dilutions. Each cDNA sample was run in duplicate. The relative abundance each gene targets were normalized against that of Rn18s. The total or absolute levels of Ucp1 mRNA were calculated by multiplying the specific Ucp1 value per μg of RNA with the total amount of extracted RNA as previously described25.

Western Blot

Western blots were performed as previously described. Briefly, total protein lysates from iWAT and BAT (180 and 30 μg) samples were separated by SDS-PAGE, electrotransferred onto a polyvinylidene difluoride membrane (Immobilon-P, Millipore, Billerica, MA, USA) and probed with antibodies against Ucp1 (ab10983, Abcam, Cambridge, United Kingdom), and alpha-tubulin (T5168, Sigma-Aldrich, St. Louis, MO, USA). The antibodies dilution was 1:1000. For protein detection biotinylated secondary antibody conjugates, diluted (1:5000) and chemiluminescence (Thermo Fisher Scientific, Madrid, Spain) were used. Then, the membranes were exposed to radiograph film (Super RX, Fuji Medical X-Ray Film; Fujifilm, Tokyo, Japan) and developed with developer and fixing liquids (AGFA, Mortsel, Belgium) under appropriate dark room conditions. Protein levels were relatively quantitated by normalization with alpha-tubulin levels in the same lysate. The total or absolute protein levels were calculated by multiplying the specific Ucp1 protein level per mg homogenate protein with the total amount of homogenate protein as previously described25.

Statistical analysis

Data were analyzed using Graph Pad Prism version 6.00 for Windows (GraphPad Software, La Jolla, California, USA) and given as means ± SEM. Statistical significance was determined by two-tailed Student’s t test and one- or two-way analysis of variance (ANOVA), followed by Bonferroni post-hoc tests.

Additional Information

How to cite this article: Pazos, P. et al. Divergent responses to thermogenic stimuli in BAT and subcutaneous adipose tissue from interleukin 18 and interleukin 18 receptor 1-deficient mice. Sci. Rep. 5, 17977; doi: 10.1038/srep17977 (2015).


  1. 1.

    et al. The inflammasome-mediated caspase-1 activation controls adipocyte differentiation and insulin sensitivity. Cell metabolism 12, 593–605 (2010).

  2. 2.

    et al. Deficiency of interleukin-18 in mice leads to hyperphagia, obesity and insulin resistance. Nature medicine 12, 650–656 (2006).

  3. 3.

    , , , & Insights into the roles of the inflammatory mediators IL-1, IL-18 and PGE2 in obesity and insulin resistance. Swiss Med Wkly 138, 665–673 (2008).

  4. 4.

    , , & Interleukin 18 in the CNS. J Neuroinflammation 7, 9 (2010).

  5. 5.

    & Antisense IRAK-1 oligonucleotide blocks activation of NF-kappa B and AP-1 induced by IL-18. Immunopharmacology 49, 241–246 (2000).

  6. 6.

    et al. Interleukin-18 activates the IRAK-TRAF6 pathway in mouse EL-4 cells. Biochem Biophys Res Commun 244, 183–186 (1998).

  7. 7.

    et al. Adiponectin blocks interleukin-18-mediated endothelial cell death via APPL1-dependent AMP-activated protein kinase (AMPK) activation and IKK/NF-kappaB/PTEN suppression. J Biol Chem 283, 24889–24898 (2008).

  8. 8.

    et al. Interleukin-18 activates skeletal muscle AMPK and reduces weight gain and insulin resistance in mice. Diabetes 62, 3064–3074 (2013).

  9. 9.

    et al. Interleukin 18 activates MAPKs and STAT3 but not NF-κB in hippocampal HT-22 cells. Brain Behav Immun 40, 85–94 (2014).

  10. 10.

    et al. Mapping of the full length and the truncated interleukin-18 receptor alpha in the mouse brain. J Neuroimmunol 214, 43–54 (2009).

  11. 11.

    et al. Constitutive and LPS-regulated expression of interleukin-18 receptor beta variants in the mouse brain. Brain, behavior, and immunity 25, 483–493 (2011).

  12. 12.

    et al. IL-37: a new anti-inflammatory cytokine of the IL-1 family. Eur Cytokine Netw 22, 127–147 (2011).

  13. 13.

    et al. IL-37 is a fundamental inhibitor of innate immunity. Nature immunology 11, 1014–1022 (2010).

  14. 14.

    & Interleukin-37. Semin Immunol 25, 466–468 (2013).

  15. 15.

    et al. IL-37 requires the receptors IL-18Ralpha and IL-1R8 (SIGIRR) to carry out its multifaceted anti-inflammatory program upon innate signal transduction. Nat Immunol 16, 354–365 (2015).

  16. 16.

    et al. Interleukin-18 controls energy homeostasis by suppressing appetite and feed efficiency. Proceedings of the National Academy of Sciences of the United States of America 104, 11097–11102 (2007).

  17. 17.

    & Interleukin-18 null mutation increases weight and food intake and reduces energy expenditure and lipid substrate utilization in high-fat diet fed mice. Brain, behavior, and immunity 37, 45–53 (2014).

  18. 18.

    et al. IL-37 protects against obesity-induced inflammation and insulin resistance. Nat Commun 5, 4711 (2014).

  19. 19.

    The adipose organ at a glance. Dis Model Mech 5, 588–594 (2012).

  20. 20.

    , , & The adipose organ: white-brown adipocyte plasticity and metabolic inflammation. Obes Rev 13 Suppl 2, 83–96 (2012).

  21. 21.

    & Assessment of brown adipose tissue function. Front Physiol 4, 128 (2013).

  22. 22.

    et al. Adaptive thermogenesis and thermal conductance in wild-type and UCP1-KO mice. Am J Physiol Regul Integr Comp Physiol 299, R1396–1406 (2010).

  23. 23.

    et al. UCP1 induction during recruitment of brown adipocytes in white adipose tissue is dependent on cyclooxygenase activity. PloS one 5, e11391 (2010).

  24. 24.

    et al. UCP1 in Brite/Beige Adipose Tissue Mitochondria Is Functionally Thermogenic. Cell Rep 5, 1196–1203 (2013).

  25. 25.

    & UCP1 mRNA does not produce heat. Biochim Biophys Acta 1831, 943–949 (2013).

  26. 26.

    & Adipose tissue browning and metabolic health. Nat Rev Endocrinol 10, 24–36 (2014).

  27. 27.

    & A new era in brown adipose tissue biology: molecular control of brown fat development and energy homeostasis. Annu Rev Physiol 76, 225–249 (2014).

  28. 28.

    , & Pharmacological and nutritional agents promoting browning of white adipose tissue. Biochim Biophys Acta 1831, 969–985 (2013).

  29. 29.

    et al. Role of IL-6 in exercise training- and cold-induced UCP1 expression in subcutaneous white adipose tissue. PloS one 9, e84910 (2014).

  30. 30.

    et al. β-Aminoisobutyric acid induces browning of white fat and hepatic β-oxidation and is inversely correlated with cardiometabolic risk factors. Cell Metab 19, 96–108 (2014).

  31. 31.

    et al. Brown adipose tissue activity controls triglyceride clearance. Nat Med 17, 200–205 (2011).

  32. 32.

    et al. Oleoylethanolamide enhances beta-adrenergic-mediated thermogenesis and white-to-brown adipocyte phenotype in epididymal white adipose tissue in rat. Dis Model Mech 7, 129–141 (2014).

  33. 33.

    , & Nonshivering thermogenesis without interscapular brown adipose tissue involvement during conditioned fear in the rat. Am J Physiol Regul Integr Comp Physiol 296, R1239–1247 (2009).

  34. 34.

    et al. Alternatively activated macrophages produce catecholamines to sustain adaptive thermogenesis. Nature 480, 104–108 (2011).

  35. 35.

    et al. Meteorin-like is a hormone that regulates immune-adipose interactions to increase beige fat thermogenesis. Cell 157, 1279–1291 (2014).

  36. 36.

    , , & Pro-opiomelanocortin modulates the thermogenic and physical activity responses to high-fat feeding and markedly influences dietary fat preference. Endocrinology 148, 5331–5338 (2007).

  37. 37.

    et al. Mice with MCH ablation resist diet-induced obesity through strain-specific mechanisms. Am J Physiol Regul Integr Comp Physiol 289, R117–124 (2005).

  38. 38.

    et al. The emergence of cold-induced brown adipocytes in mouse white fat depots is determined predominantly by white to brown adipocyte transdifferentiation. Am J Physiol Endocrinol Metab 298, E1244–1253 (2010).

  39. 39.

    et al. Abnormal nonshivering thermogenesis in mice with inherited defects of fatty acid oxidation. J Clin Invest 102, 1724–1731 (1998).

  40. 40.

    et al. Prdm16 determines the thermogenic program of subcutaneous white adipose tissue in mice. J Clin Invest 121, 96–105 (2011).

  41. 41.

    et al. A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 92, 829–839 (1998).

  42. 42.

    et al. Ablation of PRDM16 and beige adipose causes metabolic dysfunction and a subcutaneous to visceral fat switch. Cell 156, 304–316 (2014).

  43. 43.

    et al. Role of caspase-1 in nuclear translocation of IL-37, release of the cytokine, and IL-37 inhibition of innate immune responses. Proc Natl Acad Sci USA 111, 2650–2655 (2014).

  44. 44.

    et al. Adiponectin Enhances Cold-Induced Browning of Subcutaneous Adipose Tissue via Promoting M2 Macrophage Proliferation. Cell metabolism 22, 279–290 (2015).

  45. 45.

    , & Versatile functions for IL-6 in metabolism and cancer. Trends in immunology 36, 92–101 (2015).

  46. 46.

    et al. Toll-like receptor-induced changes in glycolytic metabolism regulate dendritic cell activation. Blood 115, 4742–4749 (2010).

  47. 47.

    & Orchestration of metabolism by macrophages. Cell metabolism 15, 432–437 (2012).

  48. 48.

    et al. Signaling by IL-6 promotes alternative activation of macrophages to limit endotoxemia and obesity-associated resistance to insulin. Nature immunology 15, 423–430 (2014).

  49. 49.

    et al. A switch from white to brown fat increases energy expenditure in cancer-associated cachexia. Cell metabolism 20, 433–447 (2014).

  50. 50.

    et al. The structural basis for receptor recognition of human interleukin-18. Nat Commun 5, 5340 (2014).

  51. 51.

    & Identification of a truncated splice variant of IL-18 receptor alpha in the human and rat, with evidence of wider evolutionary conservation. PeerJ 2, e560 (2014).

  52. 52.

    et al. The brain and brown fat. Ann Med 47, 150–168 (2015).

  53. 53.

    et al. GLP-1 Agonism Stimulates Brown Adipose Tissue Thermogenesis and Browning Through Hypothalamic AMPK. Diabetes 63, 3346–3358 (2014).

  54. 54.

    et al. Vertical sleeve gastrectomy is effective in two genetic mouse models of glucagon-like Peptide 1 receptor deficiency. Diabetes 62, 2380–2385 (2013).

  55. 55.

    , , , & Interleukin 6 deficiency modulates the hypothalamic expression of energy balance regulating peptides during pregnancy in mice. PloS one 8, e72339 (2013).

  56. 56.

    et al. Central melanin-concentrating hormone influences liver and adipose metabolism via specific hypothalamic nuclei and efferent autonomic/JNK1 pathways. Gastroenterology 144, 636–649 e636 (2013).

Download references


The authors thank Eva Vigo and Ana Senra for excellent technical assistance. The thermographic camera and Prdm16 gene primers were kindly lent and donated by prof. Rubén Nogueiras Research Center of Molecular Medicine and Chronic Diseases (CIMUS). This work has been supported by European Community (FP7/2007n° 245009: “NeuroFAST”), Ministerio de Economía y Competitividad (PP and MCGG: BFU2007–62683/BFI and PP, MCGG and CD: CIBERobn (CB06/03)) and Xunta de Galicia Grants (MCGG and LL: PGIDIT06PXIB208067PR and GPC2014/030). CIBER de Fisiopatología de la Obesidad y Nutrición is an initiative of ISCIII.

Author information


  1. Department of Physiology/Research Center of Molecular Medicine and Chronic Diseases (CIMUS). University of Santiago de Compostela

    • Patricia Pazos
    • , Luis Lima
    • , Sulay Tovar
    • , David González-Touceda
    • , Carlos Diéguez
    •  & María C. García
  2. Instituto de Investigación Sanitaria de Santiago de Compostela, Santiago de Compostela, Spain

    • Patricia Pazos
    • , Luis Lima
    • , Sulay Tovar
    • , David González-Touceda
    • , Carlos Diéguez
    •  & María C. García
  3. CIBER Fisiopatología Obesidad y Nutrición (CB06/03), Instituto de Salud Carlos III (ISCIII), Ministerio de Economía y Competitividad (MINECO), Spain

    • Patricia Pazos
    • , Sulay Tovar
    • , David González-Touceda
    • , Carlos Diéguez
    •  & María C. García


  1. Search for Patricia Pazos in:

  2. Search for Luis Lima in:

  3. Search for Sulay Tovar in:

  4. Search for David González-Touceda in:

  5. Search for Carlos Diéguez in:

  6. Search for María C. García in:


Conceived and designed the experiments: L.L., C.D., S.T. and M.C.G.G. Performed the experiments: P.P., L.L., S.T., D.G. and M.C.G.G. Analysed the data: M.C.G.G. Wrote the paper: P.P., L.L., C.D. and M.C.G.G.

Competing interests

The authors declare no competing financial interests.

Corresponding author

Correspondence to María C. García.

Supplementary information

About this article

Publication history






By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.